The North America Radiation Oncology Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Ionizing radiation from radioactive sources or beam generators is used in radiation therapy to destroy cancer cells that have developed in the patient's body. To deliver higher radiation doses to the tumor while sparing nearby healthy tissues, market companies are investing a lot of money in research and development of new multi-modality diagnostics procedures in radiation oncology. One such treatment approach that enables giving the tumor fewer high radiation oncology doses is the hypo fractionated radiation therapy (HFRT) process.
Hypofractionation is currently clinically accepted, however for effective application, it would need to be combined with cutting-edge functional imaging methods. Since HFRT eliminates the need for frequent hospital visits, which lowers the risk of virus exposure, it has become more widely used in medical facilities for the treatment of head and neck cancer due to the prevalence of coronavirus disease. The American and European Societies for Radiotherapy and Oncology (ASTRO-ESTRO) produced a consensus statement during the COVID-19 pandemic that strongly encourages the use of HFRT.
In 2019, North America spent 16.32% of its GDP on healthcare. Due to the things such as technological development and the availability of less invasive cancer treatment choices in developed countries, the market is growing. One in sixteen Americans may have lung cancer treatment in their lifetime, according to the National Cancer Institute of the US Department of Health and Human Services. Lung cancer affected more than 228,000 people in the US in 2018, with a new case being identified every 2.3 minutes.
The US market dominated the North America Radiation Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,252.9 million by 2028.The Canada market is poised to grow at a CAGR of 9.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8.7% during (2022 - 2028).
Based on Application, the market is segmented into Breast Cancer, Gynecological Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Head & Neck Cancer, Gynecological Cancer and Others. Based on Type, the market is segmented into External Beam Radiation Therapy and Internal Beam Radiation Therapy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Radiation Oncology Market is Estimated to reach $12.8 Billion by 2028, at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Breast Cancer
- Gynecological Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Head & Neck Cancer
- Gynecological Cancer
- Others
By Type
- External Beam Radiation Therapy
- Internal Beam Radiation Therapy
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Varian Medical Systems, Inc.
- Ion Beam Applications SA
- Elekta AB
- Accuray Incorporated
- Nordion Inc. (Sotera Health LLC)
- Isoray Inc.
- Mevion Medical Systems, Inc.
- Provision Healthcare
- Panacea Medical Technologies Pvt. Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Radiation Oncology Market, by Application
1.4.2 North America Radiation Oncology Market, by Type
1.4.3 North America Radiation Oncology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2020, Nov – 2022, May) Leading Players
Chapter 4. North America Radiation Oncology Market by Application
4.1 North America Breast Cancer Market by Country
4.2 North America Gynecological Cancer Market by Country
4.3 North America Colorectal Cancer Market by Country
4.4 North America Lung Cancer Market by Country
4.5 North America Prostate Cancer Market by Country
4.6 North America Head & Neck Cancer Market by Country
4.7 North America Gynecological Cancer Market by Country
4.8 North America Other Application Market by Country
Chapter 5. North America Radiation Oncology Market by Type
5.1 North America External Beam Radiation Therapy Market by Country
5.2 North America Internal Beam Radiation Therapy Market by Country
Chapter 6. North America Radiation Oncology Market by Country
6.1 US Radiation Oncology Market
6.1.1 US Radiation Oncology Market by Application
6.1.2 US Radiation Oncology Market by Type
6.2 Canada Radiation Oncology Market
6.2.1 Canada Radiation Oncology Market by Application
6.2.2 Canada Radiation Oncology Market by Type
6.3 Mexico Radiation Oncology Market
6.3.1 Mexico Radiation Oncology Market by Application
6.3.2 Mexico Radiation Oncology Market by Type
6.4 Rest of North America Radiation Oncology Market
6.4.1 Rest of North America Radiation Oncology Market by Application
6.4.2 Rest of North America Radiation Oncology Market by Type
Chapter 7. Company Profiles
7.1 Becton, Dickinson and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Varian Medical Systems, Inc. (Siemens Healthineers)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.3 Ion Beam Applications SA
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Product Launches and Product Expansions:
7.4 Elekta AB
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.5 Accuray Incorporated
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Nordion Inc. (Sotera Health LLC)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 Isoray Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.8 Mevion Medical Systems, Inc.
7.8.1 Company Overview
7.9 Provision Healthcare
7.9.1 Company Overview
7.10. Panacea Medical Technologies Pvt. Ltd.
7.10.1 Company Overview
TABLE 1 North America Radiation Oncology Market, 2018 - 2021, USD Million
TABLE 2 North America Radiation Oncology Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Radiation Oncology Market
TABLE 4 Product Launches And Product Expansions– Radiation Oncology Market
TABLE 5 Acquisition and Mergers– Radiation Oncology Market
TABLE 6 North America Radiation Oncology Market by Application, 2018 - 2021, USD Million
TABLE 7 North America Radiation Oncology Market by Application, 2022 - 2028, USD Million
TABLE 8 North America Breast Cancer Market by Country, 2018 - 2021, USD Million
TABLE 9 North America Breast Cancer Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Gynecological Cancer Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Gynecological Cancer Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Colorectal Cancer Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Colorectal Cancer Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Lung Cancer Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Lung Cancer Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Prostate Cancer Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Prostate Cancer Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Head & Neck Cancer Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Head & Neck Cancer Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Gynecological Cancer Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Gynecological Cancer Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Other Application Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Other Application Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Radiation Oncology Market by Type, 2018 - 2021, USD Million
TABLE 25 North America Radiation Oncology Market by Type, 2022 - 2028, USD Million
TABLE 26 North America External Beam Radiation Therapy Market by Country, 2018 - 2021, USD Million
TABLE 27 North America External Beam Radiation Therapy Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Internal Beam Radiation Therapy Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Internal Beam Radiation Therapy Market by Country, 2022 - 2028, USD Million
TABLE 30 North America Radiation Oncology Market by Country, 2018 - 2021, USD Million
TABLE 31 North America Radiation Oncology Market by Country, 2022 - 2028, USD Million
TABLE 32 US Radiation Oncology Market, 2018 - 2021, USD Million
TABLE 33 US Radiation Oncology Market, 2022 - 2028, USD Million
TABLE 34 US Radiation Oncology Market by Application, 2018 - 2021, USD Million
TABLE 35 US Radiation Oncology Market by Application, 2022 - 2028, USD Million
TABLE 36 US Radiation Oncology Market by Type, 2018 - 2021, USD Million
TABLE 37 US Radiation Oncology Market by Type, 2022 - 2028, USD Million
TABLE 38 Canada Radiation Oncology Market, 2018 - 2021, USD Million
TABLE 39 Canada Radiation Oncology Market, 2022 - 2028, USD Million
TABLE 40 Canada Radiation Oncology Market by Application, 2018 - 2021, USD Million
TABLE 41 Canada Radiation Oncology Market by Application, 2022 - 2028, USD Million
TABLE 42 Canada Radiation Oncology Market by Type, 2018 - 2021, USD Million
TABLE 43 Canada Radiation Oncology Market by Type, 2022 - 2028, USD Million
TABLE 44 Mexico Radiation Oncology Market, 2018 - 2021, USD Million
TABLE 45 Mexico Radiation Oncology Market, 2022 - 2028, USD Million
TABLE 46 Mexico Radiation Oncology Market by Application, 2018 - 2021, USD Million
TABLE 47 Mexico Radiation Oncology Market by Application, 2022 - 2028, USD Million
TABLE 48 Mexico Radiation Oncology Market by Type, 2018 - 2021, USD Million
TABLE 49 Mexico Radiation Oncology Market by Type, 2022 - 2028, USD Million
TABLE 50 Rest of North America Radiation Oncology Market, 2018 - 2021, USD Million
TABLE 51 Rest of North America Radiation Oncology Market, 2022 - 2028, USD Million
TABLE 52 Rest of North America Radiation Oncology Market by Application, 2018 - 2021, USD Million
TABLE 53 Rest of North America Radiation Oncology Market by Application, 2022 - 2028, USD Million
TABLE 54 Rest of North America Radiation Oncology Market by Type, 2018 - 2021, USD Million
TABLE 55 Rest of North America Radiation Oncology Market by Type, 2022 - 2028, USD Million
TABLE 56 Key information – Becton, Dickinson and Company
TABLE 57 Key Information –-Varian Medical Systems, Inc.
TABLE 58 Key Information – Ion Beam Applications SA
TABLE 59 key Information – Elekta AB
TABLE 60 Key Information – Accuray Incorporated
TABLE 61 Key Information – Nordion Inc.
TABLE 62 Key Information – Isoray Inc.
TABLE 63 Key Information – Mevion Medical Systems, Inc.d
TABLE 64 Key Information – Provision Healthcare
TABLE 65 Key Information – Panacea Medical Technologies Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2020, NOV – 2022, may) Leading Players
FIG 5 Swot analysis: Becton, Dickinson and company
FIG 6 Recent strategies and developments: Varian Medical Systems, Inc.
FIG 7 Recent strategies and developments: Ion Beam Applications SA
FIG 8 Recent strategies and developments: Elekta AB
FIG 9 Recent strategies and developments: Accuray Incorporated